China Pharma Holdings (CPHI) Assets Average (2011 - 2026)
China Pharma Holdings' (CPHI) quarterly Assets Average came in at $38.1 million in Q1 2026, up 161.62% YoY from $14.6 million in Q1 2025, and up 62.68% on a QoQ basis from $23.4 million in Q4 2025.
China Pharma Holdings (CPHI) Assets Average (2011 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 16 years of Assets Average data on file, last reported at $38.1 million in Q1 2026.
- Quarterly Assets Average rose 161.62% year-over-year to $38.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.1 million (up 161.62% YoY) and the FY2025 annual result came in at $22.9 million, up 46.34% from the prior year.
- Assets Average grew to $38.1 million in Q1 2026, from $23.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $38.1 million in Q1 2026 to a low of $13.9 million in Q3 2024.
- A 5-year average of $18.0 million and a median of $16.3 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average declined 19.57% — and 2026, when it jumped 161.62%.
- Tracing CPHI's Assets Average over 5 years: stood at $17.0 million in 2022, then retreated by 6.37% to $15.9 million in 2023, then decreased by 10.9% to $14.2 million in 2024, then surged by 65.08% to $23.4 million in 2025, then surged by 62.68% to $38.1 million in 2026.
- The last three Assets Average figures came in at $38.1 million (Q1 2026), $23.4 million (Q4 2025), and $14.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 44.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.07 Mn |
| Dec 31, 2025 | 23.40 Mn |
| Sep 30, 2025 | 14.79 Mn |
| Jun 30, 2025 | 13.99 Mn |
| Mar 31, 2025 | 14.55 Mn |
| Dec 31, 2024 | 14.18 Mn |
| Sep 30, 2024 | 13.86 Mn |
| Jun 30, 2024 | 15.23 Mn |
| Mar 31, 2024 | 16.33 Mn |
| Dec 31, 2023 | 15.91 Mn |
| Sep 30, 2023 | 15.53 Mn |
| Jun 30, 2023 | 16.53 Mn |
| Mar 31, 2023 | 17.57 Mn |
| Dec 31, 2022 | 16.99 Mn |
| Sep 30, 2022 | 17.06 Mn |
| Jun 30, 2022 | 19.48 Mn |
| Mar 31, 2022 | 21.85 Mn |
| Dec 31, 2021 | 20.42 Mn |
| Sep 30, 2021 | 19.06 Mn |
| Jun 30, 2021 | 19.90 Mn |